Toll-like receptor-mediated innate immune responses by recognition of the recombinant dormancy-associated Mycobacterium tuberculosis proteins Rv2659c and Rv1738.

Tuberculosis (TB) caused by Mycobacterium tuberculosis (Mtb) poses a major threat to the global public health. Importantly, latent tuberculosis infection (LTBI) still impedes the elimination of TB incidence since it has a substantial risk to develop active disease. A multi-stage subunit vaccine comp...

Full description

Bibliographic Details
Main Authors: Chutiphon Saelee, Jariya Hanthamrongwit, Phyu Thwe Soe, Prasong Khaenam, Naharuthai Inthasin, Pattama Ekpo, Patchanee Chootong, Chaniya Leepiyasakulchai
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0273517
_version_ 1811168398168555520
author Chutiphon Saelee
Jariya Hanthamrongwit
Phyu Thwe Soe
Prasong Khaenam
Naharuthai Inthasin
Pattama Ekpo
Patchanee Chootong
Chaniya Leepiyasakulchai
author_facet Chutiphon Saelee
Jariya Hanthamrongwit
Phyu Thwe Soe
Prasong Khaenam
Naharuthai Inthasin
Pattama Ekpo
Patchanee Chootong
Chaniya Leepiyasakulchai
author_sort Chutiphon Saelee
collection DOAJ
description Tuberculosis (TB) caused by Mycobacterium tuberculosis (Mtb) poses a major threat to the global public health. Importantly, latent tuberculosis infection (LTBI) still impedes the elimination of TB incidence since it has a substantial risk to develop active disease. A multi-stage subunit vaccine comprising active and latency antigens of Mtb has been raised as the promising vaccine to trigger immune protection against all stages of TB. Therefore, the discovery of new antigens that could trigger broad immune response is essential. While current development of TB vaccine mainly focuses on protective immunity mediated by adaptive immune response, the knowledge on triggering the innate immune response by antigens is still limited. We showed that recombinant dormancy-associated Mtb proteins Rv2659c and Rv1738 were recognized by human innate immune recognition molecules, Toll-like receptors (TLRs) 2 and 4 by using HEK-Blue™ hTLR2/hTLR4 systems. We further demonstrated that these two proteins activated phosphorylated NF-κB p65 (Ser536) in the human CD14+ blood cells. We also investigated that these two proteins significantly induced level of pro- and anti-inflammatory cytokines (IL-1β, IL-6, IL-8, IL-10 and TNF-α) which were mediated through TLR2 and TLR4 pathways in human peripheral blood mononuclear cells (hPBMCs). These findings suggest that proteins Rv2659c and Rv1738 stimulated innate immune response targeting TLR2 and TLR4 to produce inflammatory cytokines, and their benefits would be valuable for the development of an effective prophylactic tuberculosis vaccine.
first_indexed 2024-04-10T16:25:38Z
format Article
id doaj.art-4442c40dd70344acb0775f35d5936983
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-10T16:25:38Z
publishDate 2022-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-4442c40dd70344acb0775f35d59369832023-02-09T05:32:25ZengPublic Library of Science (PLoS)PLoS ONE1932-62032022-01-01179e027351710.1371/journal.pone.0273517Toll-like receptor-mediated innate immune responses by recognition of the recombinant dormancy-associated Mycobacterium tuberculosis proteins Rv2659c and Rv1738.Chutiphon SaeleeJariya HanthamrongwitPhyu Thwe SoePrasong KhaenamNaharuthai InthasinPattama EkpoPatchanee ChootongChaniya LeepiyasakulchaiTuberculosis (TB) caused by Mycobacterium tuberculosis (Mtb) poses a major threat to the global public health. Importantly, latent tuberculosis infection (LTBI) still impedes the elimination of TB incidence since it has a substantial risk to develop active disease. A multi-stage subunit vaccine comprising active and latency antigens of Mtb has been raised as the promising vaccine to trigger immune protection against all stages of TB. Therefore, the discovery of new antigens that could trigger broad immune response is essential. While current development of TB vaccine mainly focuses on protective immunity mediated by adaptive immune response, the knowledge on triggering the innate immune response by antigens is still limited. We showed that recombinant dormancy-associated Mtb proteins Rv2659c and Rv1738 were recognized by human innate immune recognition molecules, Toll-like receptors (TLRs) 2 and 4 by using HEK-Blue™ hTLR2/hTLR4 systems. We further demonstrated that these two proteins activated phosphorylated NF-κB p65 (Ser536) in the human CD14+ blood cells. We also investigated that these two proteins significantly induced level of pro- and anti-inflammatory cytokines (IL-1β, IL-6, IL-8, IL-10 and TNF-α) which were mediated through TLR2 and TLR4 pathways in human peripheral blood mononuclear cells (hPBMCs). These findings suggest that proteins Rv2659c and Rv1738 stimulated innate immune response targeting TLR2 and TLR4 to produce inflammatory cytokines, and their benefits would be valuable for the development of an effective prophylactic tuberculosis vaccine.https://doi.org/10.1371/journal.pone.0273517
spellingShingle Chutiphon Saelee
Jariya Hanthamrongwit
Phyu Thwe Soe
Prasong Khaenam
Naharuthai Inthasin
Pattama Ekpo
Patchanee Chootong
Chaniya Leepiyasakulchai
Toll-like receptor-mediated innate immune responses by recognition of the recombinant dormancy-associated Mycobacterium tuberculosis proteins Rv2659c and Rv1738.
PLoS ONE
title Toll-like receptor-mediated innate immune responses by recognition of the recombinant dormancy-associated Mycobacterium tuberculosis proteins Rv2659c and Rv1738.
title_full Toll-like receptor-mediated innate immune responses by recognition of the recombinant dormancy-associated Mycobacterium tuberculosis proteins Rv2659c and Rv1738.
title_fullStr Toll-like receptor-mediated innate immune responses by recognition of the recombinant dormancy-associated Mycobacterium tuberculosis proteins Rv2659c and Rv1738.
title_full_unstemmed Toll-like receptor-mediated innate immune responses by recognition of the recombinant dormancy-associated Mycobacterium tuberculosis proteins Rv2659c and Rv1738.
title_short Toll-like receptor-mediated innate immune responses by recognition of the recombinant dormancy-associated Mycobacterium tuberculosis proteins Rv2659c and Rv1738.
title_sort toll like receptor mediated innate immune responses by recognition of the recombinant dormancy associated mycobacterium tuberculosis proteins rv2659c and rv1738
url https://doi.org/10.1371/journal.pone.0273517
work_keys_str_mv AT chutiphonsaelee tolllikereceptormediatedinnateimmuneresponsesbyrecognitionoftherecombinantdormancyassociatedmycobacteriumtuberculosisproteinsrv2659candrv1738
AT jariyahanthamrongwit tolllikereceptormediatedinnateimmuneresponsesbyrecognitionoftherecombinantdormancyassociatedmycobacteriumtuberculosisproteinsrv2659candrv1738
AT phyuthwesoe tolllikereceptormediatedinnateimmuneresponsesbyrecognitionoftherecombinantdormancyassociatedmycobacteriumtuberculosisproteinsrv2659candrv1738
AT prasongkhaenam tolllikereceptormediatedinnateimmuneresponsesbyrecognitionoftherecombinantdormancyassociatedmycobacteriumtuberculosisproteinsrv2659candrv1738
AT naharuthaiinthasin tolllikereceptormediatedinnateimmuneresponsesbyrecognitionoftherecombinantdormancyassociatedmycobacteriumtuberculosisproteinsrv2659candrv1738
AT pattamaekpo tolllikereceptormediatedinnateimmuneresponsesbyrecognitionoftherecombinantdormancyassociatedmycobacteriumtuberculosisproteinsrv2659candrv1738
AT patchaneechootong tolllikereceptormediatedinnateimmuneresponsesbyrecognitionoftherecombinantdormancyassociatedmycobacteriumtuberculosisproteinsrv2659candrv1738
AT chaniyaleepiyasakulchai tolllikereceptormediatedinnateimmuneresponsesbyrecognitionoftherecombinantdormancyassociatedmycobacteriumtuberculosisproteinsrv2659candrv1738